EGOT
geneOn this page
Also known as EGONCRNA00190
Summary
EGOT (eosinophil granule ontogeny transcript, HGNC:37129) is a long non-coding RNA gene on chromosome 3p26.1.
Biomarker of congestive heart failure.
Source: NCBI Gene 100126791 — RefSeq curated summary.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:37129 |
| Approved symbol | EGOT |
| Name | eosinophil granule ontogeny transcript |
| Location | 3p26.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | EGO, NCRNA00190 |
| Ensembl gene | ENSG00000235947 |
| Ensembl biotype | lncRNA |
| OMIM | 611662 |
| Entrez | 100126791 |
| RNAcentral | URS0000757E01 — lncRNA, 1529 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 lncRNA
ENST00000414938
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000414938 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001635469 | 4749192 | 4750010 |
| ENSE00001706854 | 4750946 | 4751590 |
Expression profiles
Bgee: expression breadth ubiquitous, 118 present calls, max score 70.67.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.9557 / max 84.1220, expressed in 179 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 40834 | 0.9557 | 179 |
Top tissues by expression
210 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| bone marrow cell | CL:0002092 | 70.67 | silver quality |
| caput epididymis | UBERON:0004358 | 70.66 | gold quality |
| metanephros cortex | UBERON:0010533 | 69.90 | gold quality |
| islet of Langerhans | UBERON:0000006 | 69.82 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 69.37 | gold quality |
| sural nerve | UBERON:0015488 | 67.36 | silver quality |
| cortex of kidney | UBERON:0001225 | 66.56 | gold quality |
| kidney | UBERON:0002113 | 65.91 | gold quality |
| colonic epithelium | UBERON:0000397 | 64.32 | silver quality |
| pancreas | UBERON:0001264 | 62.88 | gold quality |
| adrenal tissue | UBERON:0018303 | 62.39 | gold quality |
| metanephros | UBERON:0000081 | 61.18 | gold quality |
| calcaneal tendon | UBERON:0003701 | 60.70 | gold quality |
| body of pancreas | UBERON:0001150 | 59.68 | gold quality |
| tonsil | UBERON:0002372 | 57.61 | gold quality |
| cauda epididymis | UBERON:0004360 | 57.43 | gold quality |
| gall bladder | UBERON:0002110 | 56.84 | gold quality |
| right uterine tube | UBERON:0001302 | 56.04 | gold quality |
| vagina | UBERON:0000996 | 55.14 | gold quality |
| corpus epididymis | UBERON:0004359 | 54.87 | gold quality |
| tendon | UBERON:0000043 | 54.45 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 54.33 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 54.04 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 53.48 | gold quality |
| uterine cervix | UBERON:0000002 | 53.42 | gold quality |
| esophagus mucosa | UBERON:0002469 | 53.31 | gold quality |
| cerebellar vermis | UBERON:0004720 | 53.20 | gold quality |
| adrenal cortex | UBERON:0001235 | 52.82 | gold quality |
| pituitary gland | UBERON:0000007 | 52.11 | gold quality |
| adrenal gland | UBERON:0002369 | 52.09 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.80 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 10)
- EGO is a novel ncRNA gene expressed during eosinophil development and is necessary for normal MBP and EDN transcript expression. (PMID:17351112)
- EGOT may play an important role in breast cancer progression and prognosis and may serve as a new potential prognostic target in breast cancer patients. (PMID:26159853)
- Our results suggest that EGOT is a lncRNA induced after infection that increases viral replication by antagonizing the antiviral response. (PMID:27283940)
- Upregulation of lncRNA EGOT by transfection of 786O and ACHN RCC cells with pcDNA3.1EGOT suppressed cell proliferation, migration and invasion, and induced RCC cell apoptosis. (PMID:28901455)
- EGOT functions as an oncogene in GC, and may be useful as a conceivable diagnostic and prognostic biomarker for GC tumorigenesis. (PMID:29209988)
- EGOT is involved in the progression of head and neck squamous cell carcinomas (HSNCC) and seems particularly associated with virus-related forms of HNSCC. (PMID:30786685)
- EGOT-enhancing autophagy sensitizes paclitaxel cytotoxicity via upregulation of ITPR1 expression by RNA-RNA and RNA-protein interactions in human breast cancer. (PMID:30999914)
- LncRNA EGOT decreases breast cancer cell viability and migration via inactivation of the Hedgehog pathway. (PMID:32150666)
- Comprehensive Analysis of Competing Endogenous RNA Network Focusing on Long Noncoding RNA Involved in Cirrhotic Hepatocellular Carcinoma. (PMID:34258170)
- Evaluation of long non-coding RNAs EGOT, NRAV, NRIR and mRNAs ISG15 and IFITM3 expressions in COVID-19 patients. (PMID:38184893)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): mucosulfatidosis, spinocerebellar ataxia type 15/16